Navigation Links
New Foam Treatment for Varicose Veins
Date:3/18/2008

Study says it passed safety tests and is relatively painless

TUESDAY, March 18 (HealthDay News) -- A new foam for treatment of varicose veins proved safe in patients, according to the results of a Phase II clinical trial.

The trial found that use of injectable Varisolve microfoam didn't cause any neurological, visual or cardiac changes in a small group of patients with a common heart defect.

Since 1997, injectable sclerosant foams have been a standard treatment for spider veins and small varicose veins. These foams are typically made by mixing a sclerosant -- an irritant that causes damage to the vein wall and subsequent scarring -- with room air. Varisolve is made with carbon dioxide and is relatively painless compared to other sclerosants, which can cause burning, according to Dr. John D. Regan, clinical director of the interventional section in the department of radiology at Wake Forest University Baptist Medical Center.

Regan was expected to present the study's findings March 18 in Washington, D.C., at the annual scientific meeting of the Society of Interventional Radiology. The study was funded by BTG International, which makes Varisolve.

The 28 patients studied so far had right-to-left shunt in their hearts. This common, usually asymptomatic heart defect affects about one-quarter of the population. In people with this defect, there's an increased risk that bubbles from injectable foams to treat varicose veins will cross the shunt and go to the brain or heart without being filtered in the lungs, Regan said.

While tiny bubbles were detected in the blood of 90 percent of the 28 patients treated with Varisolve, there were no signs of neurological, visual or cardiac changes during monitoring using ultrasound, MRI and other methods. The study will continue until 50 patients have been treated and monitored.

More information

The U.S. National Women's Health Information Center has more about varicose veins.



-- Robert Preidt



SOURCE: Wake Forest University Baptist Medical Center, news release, March 17, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Interventional Radiology Treatment Shows Hope for People With Complications from Bone Marrow, Stem Cell Transplants
2. Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists
3. Researchers study new drug and indications for heated chemotherapy treatment
4. Combo Treatment Ups Survival When Cancer Spreads to Abdominal Lining
5. Damaged veins heal faster with heparin treatment, laboratory study finds
6. Current and Emerging Therapies Have No Advantage Over Pfizers Lyrica in Their Effect on Patients Quality of Life in the Treatment of Diabetic Neuropathy
7. Novel discovery by Einstein scientists could lead to much-needed kidney failure treatment
8. Scripps Florida awarded $7.6 million grant to develop novel treatment for Parkinsons disease
9. More Clinical Data Required to Support European Approval of Desvenlafaxine as a Potential Treatment for Vasomotor Symptoms
10. New potential treatment for muscular dystrophy appears to be safe
11. Leading researchers honored for progress in cancer prevention, detection and treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Foam Treatment for Varicose Veins
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... responds to and which He does not. Yisrayl says with so many titles and ... true name, but he says with a little Scripture, backed with a lot of research, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced the ... implement a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software ... in long-term care, Brooke Grove now has the capability to achieve its goal ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Rob Lowe is ... now he has leant his presence to an educational purpose as the host of ... important one being cancer. In a recent episode, the series focuses on thyroid cancer. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
(Date:4/19/2017)... 19, 2017 The Mobile X-Ray product segment is ... CAGR during the forecast period Mobile X-Ray segment ... digital mobile X-Ray devices market, which is estimated to be ... at a CAGR of 7% over the forecast period. Mobile ... more than US$ 100 Mn in 2017 over 2016. The ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
Breaking Medicine Technology: